C
KROS icon

Chescapmanager’s Keros Therapeutics KROS Stock Holding History

Chescapmanager’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,105
Closed -$402K – 46
2023
Q4 		$402K Hold
10,105
– – 0.09% 39
2023
Q3 		$322K Hold
10,105
– – 0.08% 39
2023
Q2 		$406K Hold
10,105
– – 0.1% 38
2023
Q1 		$431K Hold
10,105
– – 0.12% 41
2022
Q4 		$485K Hold
10,105
– – 0.15% 35
2022
Q3 		$380K Hold
10,105
– – 0.12% 39
2022
Q2 		$279K Hold
10,105
– – 0.09% 39
2022
Q1 		$550K Hold
10,105
– – 0.12% 44
2021
Q4 		$591K Hold
10,105
– – 0.09% 54
2021
Q3 		$400K Hold
10,105
– – 0.06% 54
2021
Q2 		$429K Buy
+10,105
New +$547K 0.07% 60

Other funds holding KROS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return